That's more a don't-leave-money-on-the-table price.The ‘fantasy numbers’ are the prices charged by drug companies.Which is why the Medicare for All approach doesn't work--it's based on fantasy numbers that are forced on the providers.Same as now except that there is only a single payer.
And herein lies the other problem: In the US, Medicaid and increasingly Medicare reimbursements don’t cover the cost of service provided. Private insurers follow Medicare for their reimbursement fee schedule
Same as we can't just adopt the drug prices from the UHC countries--once again, fantasy numbers being forced on the providers (drug companies.)
I would love a good universal system--but I have major doubts about whether it actually can be done. The reality is that we are to a large part measuring how well the problems can be hidden rather than how well the systems actually work.
The fantasy numbers I am talking about are they price drugs at something above the marginal cost, leaving the US market to fund the R&D.
You can't set US prices to their prices without causing R&D to come to a screeching halt. But that does not mean you can't find a fair price for everyone.
And this is supposed to be a rebuttal?Medical providers can and do come up with cost savings. Those are most effective when not dictated by higher management but are directed by the work experiences of those performing whatever tasks.
The problem in the US is that politicians like to play games with people’s lives by insisting that there is waste and fraud and cutting funding to fit their political narrative.